draashish · @draashish
12 followers · 12 posts · Server med-mastodon.com#STRONGHF showed an 8% absolute risk reduction in the primary end points {The primary endpoint occurred in 15.2% of patients in the high-intensity arm vs 23.1% in the usual care group (hazard ratio, 0.66; 95% CI, 0.50 - 0.86; P = .0021)} Although the benefits are attributed to maximal up-titration of GDMT (w/o SGLT2-I), High-intensity care, post DC, was the key 2 it. Will HealthCare systems make the invstmnt & bolster d talk of outcomes? #MedMastodon #GDMTworks #cardiology #internalmedicine
#stronghf #MedMastodon #gdmtworks #cardiology #internalmedicine
Rohan Khera :verified: · @rohankhera
68 followers · 57 posts · Server mstdn.social
A terrific #AHA22 update by star #YaleCardiology fellows.
#STRONGHF #BESTCLI #ISCHEMIA_EXTEND #EMPAKidney #DCP #CRISPR
Watch full video here:
youtu.be/9NqCGPe7POM
#crispr #dcp #empakidney #ischemia_extend #bestcli #stronghf #yalecardiology #aha22
Rohan Khera :verified: · @rohankhera
74 followers · 70 posts · Server mstdn.socialA terrific #AHA22 update by star #YaleCardiology fellows.
#STRONGHF #BESTCLI #ISCHEMIA_EXTEND #EMPAKidney #DCP #CRISPR
Watch full video here:
youtu.be/9NqCGPe7POM
#crispr #dcp #empakidney #ischemia_extend #bestcli #stronghf #yalecardiology #aha22
Rohan Khera :verified: · @rohankhera
69 followers · 55 posts · Server mstdn.social
A special @YaleCardiology@twitter.com grand rounds, where CV fellows Tom Breen and Inga Melvinsdottir are leading an update from #AHA22
#STRONGHF #BESTCLI #ISCHEMIA_EXTEND #EMPAKidney #DCP #CRISPR
LIVE here:
https://youtu.be/9NqCGPe7POM
@ericjvelazquez@twitter.com @edwardmillermd@twitter.com @YaleMed@twitter.com
#crispr #dcp #empakidney #ischemia_extend #bestcli #stronghf #aha22